Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine in Interstitial Cystitis
NCT01990898Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Nov 2013
- Primary completion
- Oct 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclosporine in interstitial cystitis (IC), sponsored by Cleveland Clinic. Primary endpoint: Symptom Improvement of Interstitial Cystitis at 3 months. Started Nov 2013; status: completed.
02
Drugs
cyclosporine
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT01990898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01990898.